nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.02	0.02	CbGpPWpGaD
Clonidine—SLC22A3—Synaptic Vesicle Pathway—SLC6A4—conduct disorder	0.0198	0.0198	CbGpPWpGaD
Clonidine—ADRA1D—Monoamine GPCRs—DRD4—conduct disorder	0.019	0.019	CbGpPWpGaD
Clonidine—ADRA2B—Monoamine GPCRs—DRD4—conduct disorder	0.0172	0.0172	CbGpPWpGaD
Clonidine—ADRA2C—Monoamine GPCRs—DRD4—conduct disorder	0.0161	0.0161	CbGpPWpGaD
Clonidine—ADRA1D—Amine ligand-binding receptors—DRD4—conduct disorder	0.016	0.016	CbGpPWpGaD
Clonidine—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.0158	0.0158	CbGpPWpGaD
Clonidine—CYP1A2—Methylation—COMT—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Clonidine—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Clonidine—ADRA2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0145	0.0145	CbGpPWpGaD
Clonidine—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.014	0.014	CbGpPWpGaD
Clonidine—ADRA2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.0135	0.0135	CbGpPWpGaD
Clonidine—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Clonidine—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.013	0.013	CbGpPWpGaD
Clonidine—ADRA1D—Monoamine GPCRs—HTR2A—conduct disorder	0.0124	0.0124	CbGpPWpGaD
Clonidine—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0118	0.0118	CbGpPWpGaD
Clonidine—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.0112	0.0112	CbGpPWpGaD
Clonidine—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.011	0.011	CbGpPWpGaD
Clonidine—ADRA2C—Monoamine GPCRs—HTR2A—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Clonidine—ADRA1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0104	0.0104	CbGpPWpGaD
Clonidine—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Clonidine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0102	0.0102	CbGpPWpGaD
Clonidine—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.01	0.01	CbGpPWpGaD
Clonidine—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.00976	0.00976	CbGpPWpGaD
Clonidine—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00943	0.00943	CbGpPWpGaD
Clonidine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00943	0.00943	CbGpPWpGaD
Clonidine—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.00916	0.00916	CbGpPWpGaD
Clonidine—ADRA2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00881	0.00881	CbGpPWpGaD
Clonidine—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00867	0.00867	CbGpPWpGaD
Clonidine—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.00851	0.00851	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Other—DRD4—conduct disorder	0.00846	0.00846	CbGpPWpGaD
Clonidine—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0077	0.0077	CbGpPWpGaD
Clonidine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00754	0.00754	CbGpPWpGaD
Clonidine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00728	0.00728	CbGpPWpGaD
Clonidine—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00716	0.00716	CbGpPWpGaD
Clonidine—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.00663	0.00663	CbGpPWpGaD
Clonidine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00639	0.00639	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0061	0.0061	CbGpPWpGaD
Clonidine—SLC22A4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00562	0.00562	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Other—HTR2A—conduct disorder	0.00552	0.00552	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00508	0.00508	CbGpPWpGaD
Clonidine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00481	0.00481	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00474	0.00474	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00467	0.00467	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00467	0.00467	CbGpPWpGaD
Clonidine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00454	0.00454	CbGpPWpGaD
Clonidine—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0043	0.0043	CbGpPWpGaD
Clonidine—SLC22A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00428	0.00428	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.00428	0.00428	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00415	0.00415	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00387	0.00387	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00385	0.00385	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00368	0.00368	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.00361	0.00361	CbGpPWpGaD
Clonidine—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.00358	0.00358	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00355	0.00355	CbGpPWpGaD
Clonidine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00342	0.00342	CbGpPWpGaD
Clonidine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00334	0.00334	CbGpPWpGaD
Clonidine—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.00334	0.00334	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00332	0.00332	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00316	0.00316	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00315	0.00315	CbGpPWpGaD
Clonidine—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.0031	0.0031	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0031	0.0031	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00305	0.00305	CbGpPWpGaD
Clonidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00299	0.00299	CbGpPWpGaD
Clonidine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00299	0.00299	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00291	0.00291	CbGpPWpGaD
Clonidine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00284	0.00284	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00277	0.00277	CbGpPWpGaD
Clonidine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00266	0.00266	CbGpPWpGaD
Clonidine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00265	0.00265	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00261	0.00261	CbGpPWpGaD
Clonidine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00257	0.00257	CbGpPWpGaD
Clonidine—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00257	0.00257	CbGpPWpGaD
Clonidine—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Clonidine—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00254	0.00254	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00252	0.00252	CbGpPWpGaD
Clonidine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00251	0.00251	CbGpPWpGaD
Clonidine—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00242	0.00242	CbGpPWpGaD
Clonidine—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00241	0.00241	CbGpPWpGaD
Clonidine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Clonidine—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00232	0.00232	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0023	0.0023	CbGpPWpGaD
Clonidine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00229	0.00229	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—COMT—conduct disorder	0.00225	0.00225	CbGpPWpGaD
Clonidine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00224	0.00224	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00223	0.00223	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.0022	0.0022	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00218	0.00218	CbGpPWpGaD
Clonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00217	0.00217	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—CGA—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00207	0.00207	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00205	0.00205	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00205	0.00205	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00204	0.00204	CbGpPWpGaD
Clonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00202	0.00202	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.00202	0.00202	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.00201	0.00201	CbGpPWpGaD
Clonidine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00198	0.00198	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00191	0.00191	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00191	0.00191	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00185	0.00185	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.00185	0.00185	CbGpPWpGaD
Clonidine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00183	0.00183	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.00182	0.00182	CbGpPWpGaD
Clonidine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00182	0.00182	CbGpPWpGaD
Clonidine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.0018	0.0018	CbGpPWpGaD
Clonidine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00179	0.00179	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00178	0.00178	CbGpPWpGaD
Clonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00177	0.00177	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00171	0.00171	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Clonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00162	0.00162	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.00156	0.00156	CbGpPWpGaD
Clonidine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00155	0.00155	CbGpPWpGaD
Clonidine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00154	0.00154	CbGpPWpGaD
Clonidine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00153	0.00153	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00151	0.00151	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.00151	0.00151	CbGpPWpGaD
Clonidine—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00147	0.00147	CbGpPWpGaD
Clonidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00146	0.00146	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.00141	0.00141	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00141	0.00141	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.00132	0.00132	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00132	0.00132	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CGA—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.0013	0.0013	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.0013	0.0013	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CGA—conduct disorder	0.00125	0.00125	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Clonidine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.0012	0.0012	CbGpPWpGaD
Clonidine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00119	0.00119	CbGpPWpGaD
Clonidine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.00115	0.00115	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.00109	0.00109	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.00108	0.00108	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CGA—conduct disorder	0.00106	0.00106	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.00102	0.00102	CbGpPWpGaD
Clonidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.001	0.001	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000999	0.000999	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CGA—conduct disorder	0.000974	0.000974	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—COMT—conduct disorder	0.000969	0.000969	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—MAOA—conduct disorder	0.000962	0.000962	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.000957	0.000957	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.000939	0.000939	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.000928	0.000928	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CGA—conduct disorder	0.000921	0.000921	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.000907	0.000907	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.000889	0.000889	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.000884	0.000884	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.000877	0.000877	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.000863	0.000863	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.000843	0.000843	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.000803	0.000803	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000798	0.000798	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000767	0.000767	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000765	0.000765	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.000746	0.000746	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CGA—conduct disorder	0.000735	0.000735	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000734	0.000734	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.000727	0.000727	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000725	0.000725	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000713	0.000713	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CGA—conduct disorder	0.000693	0.000693	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.000677	0.000677	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—EP300—conduct disorder	0.000669	0.000669	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.000666	0.000666	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.000656	0.000656	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000652	0.000652	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—EP300—conduct disorder	0.000625	0.000625	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.000613	0.000613	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000606	0.000606	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000603	0.000603	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000592	0.000592	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—COMT—conduct disorder	0.000591	0.000591	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CGA—conduct disorder	0.000587	0.000587	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—MAOA—conduct disorder	0.000587	0.000587	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—COMT—conduct disorder	0.000566	0.000566	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000562	0.000562	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.00055	0.00055	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000536	0.000536	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—EP300—conduct disorder	0.000508	0.000508	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000498	0.000498	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—COMT—conduct disorder	0.00048	0.00048	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—MAOA—conduct disorder	0.000477	0.000477	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000474	0.000474	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CGA—conduct disorder	0.000453	0.000453	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—COMT—conduct disorder	0.00044	0.00044	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—MAOA—conduct disorder	0.000437	0.000437	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000428	0.000428	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—COMT—conduct disorder	0.000416	0.000416	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—EP300—conduct disorder	0.000415	0.000415	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—MAOA—conduct disorder	0.000413	0.000413	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0004	0.0004	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.0004	0.0004	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000394	0.000394	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.00035	0.00035	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—COMT—conduct disorder	0.000332	0.000332	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—MAOA—conduct disorder	0.00033	0.00033	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000325	0.000325	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—COMT—conduct disorder	0.000313	0.000313	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MAOA—conduct disorder	0.000311	0.000311	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—COMT—conduct disorder	0.000265	0.000265	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MAOA—conduct disorder	0.000263	0.000263	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000255	0.000255	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—EP300—conduct disorder	0.000253	0.000253	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000251	0.000251	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—EP300—conduct disorder	0.000243	0.000243	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000227	0.000227	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000212	0.000212	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000209	0.000209	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—EP300—conduct disorder	0.000206	0.000206	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—COMT—conduct disorder	0.000205	0.000205	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000203	0.000203	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—EP300—conduct disorder	0.000189	0.000189	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.000185	0.000185	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—EP300—conduct disorder	0.000178	0.000178	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EP300—conduct disorder	0.000172	0.000172	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—EP300—conduct disorder	0.000142	0.000142	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—EP300—conduct disorder	0.000134	0.000134	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—EP300—conduct disorder	0.000114	0.000114	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—EP300—conduct disorder	8.77e-05	8.77e-05	CbGpPWpGaD
